Avadel Pharmaceuticals PLC (STU:AWK)
€ 10 0.15 (1.52%) Market Cap: 949.15 Mil Enterprise Value: 888.38 Mil PE Ratio: 0 PB Ratio: 13.69 GF Score: 42/100

Avadel Pharmaceuticals PLC Commercial Day Transcript

Jun 29, 2023 / 12:00PM GMT
Release Date Price: €12.7 (+1.60%)
Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director

First of all, thank you for everyone here in person and those on the webcast for joining us today for our LUMRYZ Commercial Day. We really appreciate you taking a few hours out of your Thursday morning to come and listen to a lot of the insights that we've gathered and garnered over the last couple of years as we frame out the early launch period and how we think about this unique opportunity.

So before we get started, I'll remind all of you and point your attention toward our -- all of our risk factors. We certainly may make some forward-looking statements here today and point you to our SEC filing of our 10-K for December 31, 2022, which was filed earlier this year and can be found on the Investors section of our website at www.avadel.com.

So although this is really the LUMRYZ Commercial Day, it really is, in our view, an ushering of a new oxybate therapy. It's an opportunity to not only transform Avadel into a high-growth commercial stage company but also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot